ADC Therapeutics SA
NYSE:ADCT
ADC Therapeutics SA
Pre-Tax Income
ADC Therapeutics SA
Pre-Tax Income Peer Comparison
Competitive Pre-Tax Income Analysis
Latest Figures & CAGR of Competitors
Company | Pre-Tax Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
ADC Therapeutics SA
NYSE:ADCT
|
Pre-Tax Income
-$195.4m
|
CAGR 3-Years
7%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
N/A
|
|
AC Immune SA
NASDAQ:ACIU
|
Pre-Tax Income
-CHf54.2m
|
CAGR 3-Years
4%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
N/A
|
|
CRISPR Therapeutics AG
NASDAQ:CRSP
|
Pre-Tax Income
-$150.7m
|
CAGR 3-Years
24%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
|
Basilea Pharmaceutica AG
SIX:BSLN
|
Pre-Tax Income
CHf10.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Idorsia Ltd
SIX:IDIA
|
Pre-Tax Income
-CHf820.1m
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-122%
|
CAGR 10-Years
N/A
|
|
Kuros Biosciences AG
SIX:KURN
|
Pre-Tax Income
-CHf13.3m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
See Also
What is ADC Therapeutics SA's Pre-Tax Income?
Pre-Tax Income
-195.4m
USD
Based on the financial report for Dec 31, 2023, ADC Therapeutics SA's Pre-Tax Income amounts to -195.4m USD.
What is ADC Therapeutics SA's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 5Y
-10%
Over the last year, the Pre-Tax Income growth was -26%. The average annual Pre-Tax Income growth rates for ADC Therapeutics SA have been 7% over the past three years , -10% over the past five years .